← Leaderboards
Michael Lanuti
Massachusetts General Hospital
$1,167,985
Attributed
$2,433,344
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $769.3K · FY2009–18$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,433,344 · 2
By mechanism
R01$2,274,277 · 1
R03$159,067 · 1
Top collaborators
- Peter D Caravan3 shared
- Andrew M Tager1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Carrie Elizabeth Cunningham$4,319,121
- Melissa J Suter$7,981,792
- Tayyaba Hasan$21,611,486
- Leif W Ellisen$14,503,955
- Kestutis Kveraga$4,502,104
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesSafetyClinical TrialsCancer PatientResponseChemotherapyAsbestosisApplications GrantsAnimal ModelCancer CellCancer Cell LineBreathingCancer SurgeryCancer TherapyAntineoplastic AgentsChemotherapeutic AgentCessation Of LifeBiologicalCarboxylic Ester HydrolasesChemotherapy-Oncologic ProcedureChimeric ProteinsCicatrixClinicCarboxylesterase
Grant awards (5)
PET Imaging of Pulmonary Fibrosis$752,479
R01 · FY2018 · HL
PET Imaging of Pulmonary Fibrosis$752,477
R01 · FY2017 · HL
PET Imaging of Pulmonary Fibrosis$769,321
R01 · FY2016 · HL
Prodrug enzyme therapy of pancreatic cancer mediated by oncolytic HSV vector$88,500
R03 · FY2010 · CA · contact PI
Prodrug enzyme therapy of pancreatic cancer mediated by oncolytic HSV vector$70,567
R03 · FY2009 · CA · contact PI